A Blood Stem Cell Transplant for Sickle Cell Disease

NCT03249831 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease
Sickle Cell Disorder
Hemoglobinopathies
Thalassemia
Anemia, Sickle Cell

Interventions

DRUG: Cyclophosphamide
DRUG: Pentostatin
DRUG: Rabbit anti-thymocyte globulin
DRUG: Tacrolimus
DRUG: Mycophenolate mofetil
BIOLOGICAL: CD4+ T-cell-depleted Haploidentical Hematopoietic Transplant

Sponsor

City of Hope Medical Center

Collaborators

[object Object]